{"id":6228,"date":"2020-02-26T15:13:45","date_gmt":"2020-02-26T14:13:45","guid":{"rendered":"https:\/\/www.chu-tours.fr\/?page_id=6228"},"modified":"2020-03-10T15:29:21","modified_gmt":"2020-03-10T14:29:21","slug":"cnr-vih-bibliographie","status":"publish","type":"page","link":"https:\/\/www.chu-tours.fr\/cnr-vih-bibliographie\/","title":{"rendered":"CNR-VIH &#8211; Bibliographie"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"6228\" class=\"elementor elementor-6228\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ebf9ac3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ebf9ac3\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-74ce85b\" data-id=\"74ce85b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-022cdf5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"022cdf5\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-96be919\" data-id=\"96be919\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-39d1b15 elementor-widget elementor-widget-text-editor\" data-id=\"39d1b15\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul><li>Barin F &amp; Simon F. Les outils du d\u00e9pistage de l\u2019infection par le VIH : concepts, progr\u00e8s et limites. Virologie 2013, 17(3) : 171-181. <a href=\"https:\/\/www.jle.com\/fr\/revues\/vir\/archive.phtml\" target=\"_blank\" rel=\"noopener\">disponible ici<\/a>.<\/li><li>Barin F et coll. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV1 genotypes A to E: an approach for HIV1 serological subtyping. AIDS Res Hum Retroviruses 1996, 12: 1279-1289.<\/li><li>Barin F et coll. Development and validation of an immunoassay for identification of recent Human Immunodeficiency Virus type 1 infections and its use on dried serum spots. J clin Microbiol 2005, 43 : 4441-4447.<\/li><li>Barin F et coll. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic. J med Virol 2006, 78 : S13-S18.<\/li><li>Brand D, Moreau A, Cazein F, Lot F, Pillonel J, Brunet S, Thierry D, Le Vu S, Plantier JC, Semaille C, Barin F. Characteristics of patients recently infected with HIV-1 non-B subtypes in France\u00a0: a nested study within the mandatory notification of new HIV diagnoses. J clin Microbiol 2014, 52\u00a0: 4010-4016.<\/li><li>Brand D, Capsec J, Chaillon A, Cazein F, Le Vu S, Moreau A, Pillonel J, Brunet S, Thierry D, Guillon-Grammatico L, Lot F, Barin F. HIV surveillance combining an assay for identification of very recent infections and phylogenetic analyses on dried spots. AIDS 2017, 31\u00a0: 407-416<\/li><li>Plantier JC et coll. V3 serotyping of human immunodeficiency virus type 1 infection: correlation with genotyping, limitations and identification of signature sequences. JAIDS, 1999, 20: 432-441.<\/li><li>Simon et coll. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retroviruses 2001, 17: 937-952.<\/li><li>Chaix ML et coll. Stable frequency of HIV-1 transmitted drug r\u00e9sistance in patients at the time of primary infection over 1996-2006 in France. AIDS 2009, 23 : 717-724.<\/li><li>Frange P, Meyer L, Deveau C, Tran L, Goujard C, Ghosn J, Girard PM, Morlat P, Rouzioux C,\u00a0Chaix ML; for the French ANRS CO6 PRIMO Cohort Study Group. Recent HIV-1 Infection Contributes to the Viral Diffusion over the French Territory with a Recent Increasing Frequency. PLoS One, 2012, 7(2):e31695.<\/li><li>Chaix ML et coll. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy. Clin Infect Dis 2013, 56(6) : 880-887.<\/li><li>Frange P, Meyer L, Ghosn J, Deveau C, Goujard C, Duvivier C, Tubiana R, Rouzioux C,\u00a0Chaix ML; for the ANRS CO6 PRIMO Cohort Study Group. Prevalence of CXCR4-tropic viruses in clustered transmission chains at the time of primary HIV-1 infection. Clin Microbiol Infect. 2013 May;19(5):E252-5.<\/li><li>Frange P, Assoumou L, Descamps D, Ch\u00e9ret A, Goujard C, Tran L, Gousset M, Avettand-Feno\u00ebl V, Bocket L, Fafi-Kremer S, Guinard J, Morand-Joubert L, Nicot F, Plantier JC, Rogez S, Wirden M, Rouzioux C, Meyer L, Chaix ML; French ANRS CO 6 PRIMO Cohort, the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups; HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies. J Antimicrob Chemother. 2015 Jul;70(7):2084-9.<\/li><li>Chaillon A, Essat A, Frange P, Smith DM, Delaugerre C, Barin F, Ghosn J, Pialoux G, Robineau O, Rouzioux C, Goujard C, Meyer L, Chaix ML; on behalf the ANRS PRIMO Cohort Study. Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies. Retrovirology. 2017 Feb 21;14(1):15. doi: 10.1186\/s12977-017-0339-4.<\/li><li>Descamps D et coll. Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance. J Med Virol 2006, 78 : 153-160.<\/li><li>Descamps D et coll. Increasing prevalence of transmitted drug resistance mutations and non-B subtypes circulating in antiretroviral naive chronically HIV-infected patients from 2001 to 2006\/2007 in France. JAC 2010, 65: 2620-2627.<\/li><li>Cazein et coll. Prevalence and characteristics of individuals with undiagnosed HIV infection in France: evidence from a survey on hepatitis B and C seroprevalence. JAIDS 2012, 60: e116-118.<\/li><li>Chaillon et coll. Decreased specificity of an assay for recent infection (EIA-RI) in HIV-1 infected patients on HAART : implications for incidence estimates. Clin Vaccine Immunol 2012, 19: 1248-1253.<\/li><li>Le Vu S et coll. Performance of an immunoassay at detecting recent infection among reported HIV diagnoses. AIDS 2009, 23: 1773-1779.<\/li><li>Le Vu S et coll. Population-based HIV-1 incidence in France, 2003-2008 : a modelling analysis. Lancet Infect Dis 2010, 10: 682-687.<\/li><li>Semaille C et coll. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses : experience after 2 years in France. J infect Dis 2007, 196 : 377-383.<\/li><li>Visseaux B, Assoumou L, Mahjoub N, Grude M, Trabaud MA, Raymond S, Wirden M, Morand-Joubert L, Roussel C, Montes B, Bocket L, Fafi-Kremer S, Amiel C, de Monte A, Stefic K, Pallier C, Tumiotto C, Maillard A, Vallet S, Ferre V, Bouvier-Alias M, Dina J, Signori-Schmuck A, Carles MJ, Plantier JC, Meyer L, Descamps D, Chiax ML, AC43 ANRS Resistance Group. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance but higher diversity, clustering and virulence? JAC 2020, 75: 183-193.<\/li><\/ul><h4>Donn\u00e9es \u00e9pid\u00e9miologiques :<\/h4><ul><li>Cazein F et coll. D\u00e9couvertes de s\u00e9ropositivit\u00e9 VIH et sida \u2013 France, 2003-2013. BEH 2015, 9-10 (<a href=\"http:\/\/www.invs.sante.fr\/beh\/2015\/9-10\/pdf\/2015_9-10_1.pdf\" target=\"_blank\" rel=\"noopener\" class=\"broken_link\">Consulter l&#8217;article<\/a>).<\/li><li>Capsec J et coll. Caract\u00e9ristiques des infections VIH tr\u00e8s r\u00e9centes et r\u00e9seaux de transmission \u00e0 partir des donn\u00e9es de la d\u00e9claration obligatoire, France, 2012-2014. BEH 2016, 41-42 (<a href=\"http:\/\/www.invs.sante.fr\/beh\/2016\/41-42\/pdf\/2016_41-42_4.pdf\" target=\"_blank\" rel=\"noopener\" class=\"broken_link\">Consulter l&#8217;article<\/a>).<\/li><\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ed028c6 elementor-button-danger elementor-align-center elementor-widget elementor-widget-button\" data-id=\"ed028c6\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-xl\" href=\"\/etre-soigne-et-rendre-visite-a-un-patient\/joindre-le-chru\/liste-des-services\/centre-national-de-reference-du-vih-cnr-vih\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Retour au service \" Centre national de r\u00e9f\u00e9rence du VIH (CNR VIH) \"<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Barin F &amp; Simon F. Les outils du d\u00e9pistage de l\u2019infection par le VIH : concepts, progr\u00e8s et limites. Virologie 2013, 17(3) : 171-181. disponible ici. Barin F et coll. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV1 genotypes A to E: an approach for HIV1 serological subtyping. AIDS Res Hum [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"CHRU de Tours. Bibliographie du CNR-VIH.","_seopress_titles_desc":"Bibliographie du CNR-VIH","_seopress_robots_index":"","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2025-02-12 11:15:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/www.chu-tours.fr\/wp-json\/wp\/v2\/pages\/6228"}],"collection":[{"href":"https:\/\/www.chu-tours.fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chu-tours.fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chu-tours.fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chu-tours.fr\/wp-json\/wp\/v2\/comments?post=6228"}],"version-history":[{"count":8,"href":"https:\/\/www.chu-tours.fr\/wp-json\/wp\/v2\/pages\/6228\/revisions"}],"predecessor-version":[{"id":6460,"href":"https:\/\/www.chu-tours.fr\/wp-json\/wp\/v2\/pages\/6228\/revisions\/6460"}],"wp:attachment":[{"href":"https:\/\/www.chu-tours.fr\/wp-json\/wp\/v2\/media?parent=6228"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}